Biochemical and genetic studies in cystinuria: observations on double heterozygotes of genotype I-II.
10 families with cystinuria were investigated by measuring: (a) quantitative 24 hr urinary excretion of amino acids by column chromatography; (b) endogenous renal clearances of amino acids and creatinine; (c) intestinal uptake of (34)C-labeled L-cystine, L-lysine, and L-arginine using jejunal mucosal biopsies; (d) oral cystine loading tests. All four of these were studied in the probands and the first two in a large number of the family members.49 members of 8 families were found to have a regular genetic pattern as described previously by Harris, Rosenberg, and their coworkers. Clinical or biochemical differences between the homozygotes type I (recessive cystinuria) and homozygotes type II (incompletely recessive cystinuria) have not been found. Both types excreted similarly excessive amounts of cystine, lysine, arginine, and ornithine, and had high endogenous renal clearances for these four amino acids. Some homozygotes of both types had a cystine clearance higher than the glomerular filtration rate. Jejunal mucosa from both types of homozygotes exhibited near complete inability to concentrate cystine and lysine in vitro. This was also documented in vivo with oral cystine loads. The heterozygotes type I were phenotypically normal with respect to the above four measurements. The heterozygotes type II showed moderate but definite abnormalities in their urinary excretion and their renal clearances of dibasic amino acids. Of the four amino acids concerned, cystine was the most reliable marker to differentiate between the heterozygotes type II and the homozygous normals. In this study, type III cystinuria, as described by Rosenberg, was not encountered. In two additional families, double heterozygotes of genotype I/II were found. The disease affecting these is clinically and biochemically less severe than that affecting homozygotes of either type I or type II. With respect to the four parameters used in this study, the double heterozygotes type I/II have results which are intermediate between those of the homozygotes type I and II and those of the heterozygotes type II.
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000378:metabolism*; D001120:Arginine / Q000097:blood / Q000378:metabolism; D001692:Biological Transport; D002118:Calcium / Q000652:urine; D002247:Carbon Isotopes; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000378:metabolism; D003553:Cystine / Q000097:blood / Q000378:metabolism; D003555:Cystinuria / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006579:Heterozygote; D006801:Humans; D007408:Intestinal Absorption; D007583:Jejunum; D007668:Kidney / Q000503:physiopathology; D008239:Lysine / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009952:Ornithine / Q000097:blood; D010070:Oxalates / Q000652:urine; D010375:Pedigree; D010710:Phosphates / Q000652:urine; D014527:Uric Acid / Q000097:blood / Q000652:urine
D000596:Amino Acids; D002247:Carbon Isotopes; D010070:Oxalates; D010710:Phosphates; D014527:Uric Acid; D003553:Cystine; D001120:Arginine; D003404:Creatinine; D009952:Ornithine; D008239:Lysine; D002118:Calcium